Literature DB >> 23269095

Cardiomyopathy and diastolic dysfunction in the embryo and neonate of a type 1 diabetic mouse model.

Niamh Corrigan1, Ann Treacy, Derek P Brazil, Fionnuala M McAuliffe.   

Abstract

OBJECTIVE: The purpose of this study was to examine the effect of maternal type 1 diabetes on the structure and function of the embryonic and neonatal mouse heart.
METHODS: Type 1 diabetes was induced in female C57BL6/J mice using streptozotocin. Embryonic (n = 105) and neonatal hearts (n = 46) were examined using high-frequency ultrasound (US) and a cohort of E18.5 (n = 34) and 1-day-old pup hearts (n = 27) underwent histological examination.
RESULTS: Global cardiac hypertrophy in late gestation (E18.5) was evident on US in the diabetic group compared to controls with increased interventricular septal (IVS) thickness (0.44 ± 0.08 mm vs 0.36 ± 0.08 mm, P < .05) and increased left ventricular wall thickness (0.38 ± 0.04 mm vs 0.29 mm ± 0.05, P < .01). Isovolumetric relaxation time was initially prolonged in the diabetic group but resolved by E18.5 to control values. Histological examination at E18.5 demonstrated increased transverse measurements (2.42 ± 0.72 mm/g vs 1.86 ± 0.55 mm/g, P < .05) and increased IVS thickness (0.64 ± 0.20 mm/g vs 0.43 ± 0.15 mm/g, P < .05) in diabetic embryos compared to control embryos.
CONCLUSION: Maternal hyperglycemia has severe effects on offspring with evidence of cardiac impairment and cardiac hypertrophy in the embryo. These effects persisted in the 1-day old but attenuated in the 1-week old suggesting cardiac remodeling after the hyperglycemic milieu of pregnancy is removed.

Entities:  

Keywords:  diabetes; embryogenesis; high resolution ultrasound; type 1 diabetic mouse model

Mesh:

Year:  2012        PMID: 23269095     DOI: 10.1177/1933719112466298

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  7 in total

1.  Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.

Authors:  Xue Lin; Penghua Yang; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2017-04-13       Impact factor: 8.661

Review 2.  Effect of maternal pregestational diabetes mellitus on congenital heart diseases.

Authors:  Zhi-Yan Chen; Shuang-Fa Mao; Ling-Hong Guo; Jian Qin; Li-Xin Yang; Yin Liu
Journal:  World J Pediatr       Date:  2022-07-15       Impact factor: 9.186

3.  Gestational hyperglycemia reprograms cardiac gene expression in rat offspring.

Authors:  Lara Lehtoranta; Anna Koskinen; Olli Vuolteenaho; Jukka Laine; Ville Kytö; Hanna Soukka; Eeva Ekholm; Juha Räsänen
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

4.  Analysis of maternal and fetal cardiovascular systems during hyperglycemic pregnancy in the nonobese diabetic mouse.

Authors:  Kristiina L Aasa; Kenneth K Kwong; Michael A Adams; B Anne Croy
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

5.  Electrocardiogram-gated Kilohertz Visualisation (EKV) Ultrasound Allows Assessment of Neonatal Cardiac Structural and Functional Maturation and Longitudinal Evaluation of Regeneration After Injury.

Authors:  Raphael F P Castellan; Adrian Thomson; Carmel M Moran; Gillian A Gray
Journal:  Ultrasound Med Biol       Date:  2019-11-04       Impact factor: 2.998

6.  Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy.

Authors:  Sha-sha Han; Guang Wang; Ya Jin; Zheng-lai Ma; Wei-jing Jia; Xia Wu; Xiao-yu Wang; Mei-yao He; Xin Cheng; Wei-jing Li; Xuesong Yang; Guo-sheng Liu
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

7.  Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis.

Authors:  A L Depla; L De Wit; T J Steenhuis; M G Slieker; D N Voormolen; P G Scheffer; R De Heus; B B Van Rijn; M N Bekker
Journal:  Ultrasound Obstet Gynecol       Date:  2021-04       Impact factor: 7.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.